Hereditary ovarian cancer cancer canadian. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Ovary Breast Epithelial Cells Prostate HCT116 Cells MCF-7 Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases56

Ovarian Neoplasms Neoplasms, Glandular and Epithelial Breast Neoplasms Cystadenocarcinoma, Serous Neoplasm Invasiveness Prostatic Neoplasms Carcinoma Lung Neoplasms Neoplasm Metastasis Colonic Neoplasms Stomach Neoplasms Neoplasms Genetic Predisposition to Disease Pancreatic Neoplasms Disease Progression Adenocarcinoma, Clear Cell Uterine Cervical Neoplasms Carcinoma, Endometrioid Peritoneal Neoplasms Neoplasm Recurrence, Local Adenocarcinoma, Mucinous Endometrial Neoplasms Colorectal Neoplasms Ascites Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Cell Transformation, Neoplastic Genital Neoplasms, Female Adenocarcinoma Rectal Neoplasms Cystadenocarcinoma Neoplastic Syndromes, Hereditary Neovascularization, Pathologic Fallopian Tube Neoplasms Esophageal Neoplasms Liver Neoplasms Neoplasms, Cystic, Mucinous, and Serous Neoplasms, Second Primary Head and Neck Neoplasms Neoplasms, Hormone-Dependent Mouth Neoplasms Carcinoma, Small Cell Hereditary Breast and Ovarian Cancer Syndrome Neoplasms, Radiation-Induced Neoplasms, Multiple Primary Precancerous Conditions Breast Neoplasms, Male Bone Neoplasms Gastrointestinal Neoplasms Cystadenocarcinoma, Mucinous Skin Neoplasms Disease Models, Animal Adenocarcinoma, Papillary Thyroid Neoplasms Mammary Neoplasms, Experimental

Chemicals and Drugs54

CA-125 Antigen Antineoplastic Agents Tumor Markers, Biological Neoplasm Proteins Cisplatin Paclitaxel Cancer Vaccines BRCA2 Protein BRCA1 Protein RNA, Messenger Antineoplastic Agents, Phytogenic DNA, Neoplasm RNA, Small Interfering Receptor, erbB-2 Receptors, Estrogen Tumor Suppressor Protein p53 Carboplatin Antigens, Neoplasm Epididymal Secretory Proteins Antibodies, Monoclonal Prostate-Specific Antigen Receptors, Progesterone Tamoxifen Fluorouracil MicroRNAs Receptor, Epidermal Growth Factor Tumor Suppressor Proteins Antineoplastic Agents, Hormonal Taxoids RNA, Neoplasm Transcription Factors Anticarcinogenic Agents Platinum DNA-Binding Proteins Deoxycytidine Proto-Oncogene Proteins c-akt Antigens, Tumor-Associated, Carbohydrate Organoplatinum Compounds Proto-Oncogene Proteins Antibodies, Monoclonal, Humanized Nuclear Proteins Antimetabolites, Antineoplastic Platinum Compounds Topotecan Estrogens Receptors, Androgen Antibiotics, Antineoplastic Protein Kinase Inhibitors DNA Primers Mucin-1 Protein-Serine-Threonine Kinases Vascular Endothelial Growth Factor A Androgens Contraceptives, Oral

Analytical, Diagnostic and Therapeutic Techniques and Equipment65

Early Detection of Cancer Prognosis Survival Analysis Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Survival Rate Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Risk Gene Expression Profiling Retrospective Studies Risk Factors Prospective Studies Follow-Up Studies Disease-Free Survival Registries Risk Assessment Blotting, Western Neoplasm Transplantation Odds Ratio Combined Modality Therapy Questionnaires Sensitivity and Specificity Transplantation, Heterologous Multivariate Analysis Kaplan-Meier Estimate Oligonucleotide Array Sequence Analysis Genetic Testing Drug Screening Assays, Antitumor Chemotherapy, Adjuvant Treatment Outcome Polymerase Chain Reaction Logistic Models Tumor Burden Immunohistochemistry Tissue Array Analysis Incidence Reproducibility of Results Transfection Confidence Intervals Neoplasm Grading Clinical Trials as Topic Predictive Value of Tests SEER Program Mammography Molecular Targeted Therapy Drug Administration Schedule DNA Mutational Analysis Cohort Studies Gene Knockdown Techniques Flow Cytometry Immunoenzyme Techniques Models, Biological Radiotherapy Immunotherapy Palliative Care Genetic Therapy Case-Control Studies Disease Models, Animal Enzyme-Linked Immunosorbent Assay Prevalence Mastectomy Biopsy Mammary Neoplasms, Experimental Pedigree

Psychiatry and Psychology1

Phenomena and Processes48

Genes, BRCA1 Genes, BRCA2 Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genetic Predisposition to Disease Risk Mutation Germ-Line Mutation Cell Proliferation Odds Ratio DNA Methylation Apoptosis Cell Survival Sensitivity and Specificity Genotype Cell Movement Down-Regulation Cell Growth Processes Cell Division Dose-Response Relationship, Drug Cell Cycle Polymorphism, Genetic Up-Regulation Genes, Tumor Suppressor Transfection RNA Interference Promoter Regions, Genetic Signal Transduction Gene Silencing Base Sequence Genes, Neoplasm Gene Expression Genes, p53 Heterozygote Diet Time Factors Postmenopause Drug Synergism Alleles Phenotype Phosphorylation Loss of Heterozygosity Tumor Microenvironment Epithelial-Mesenchymal Transition Menopause Epigenesis, Genetic Gene Amplification Parity

Disciplines and Occupations3

Medical Oncology Immunohistochemistry Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Questionnaires Incidence SEER Program Base Sequence Molecular Sequence Data Prevalence

Named Groups3

Survivors European Continental Ancestry Group Jews

Health Care37

Survival Analysis Survival Rate Risk Retrospective Studies Risk Factors Prospective Studies Follow-Up Studies Disease-Free Survival Registries Risk Assessment Age Factors Odds Ratio Questionnaires National Cancer Institute (U.S.)Sensitivity and Specificity Multivariate Analysis Kaplan-Meier Estimate Genetic Testing Treatment Outcome Logistic Models Incidence Reproducibility of Results Confidence Intervals Clinical Trials as Topic Predictive Value of Tests SEER Program Cohort Studies American Cancer Society Age Distribution Genetic Counseling Palliative Care Family Health Case-Control Studies Prevalence Sex Factors Parity Confounding Factors (Epidemiology)

Geographicals8

Canada United States Ontario China Japan Sweden Alberta British Columbia

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Genes, BRCA1 Ovarian Neoplasms Genes, BRCA2 Canada Neoplasms, Glandular and Epithelial Early Detection of Cancer CA-125 Antigen Breast Neoplasms Cystadenocarcinoma, Serous Cell Line, Tumor Gene Expression Regulation, Neoplastic Neoplasm Invasiveness Prostatic Neoplasms Mice, Nude Drug Resistance, Neoplasm Carcinoma Lung Neoplasms Antineoplastic Agents Neoplasm Metastasis Tumor Markers, Biological Colonic Neoplasms Neoplasm Proteins Prognosis Stomach Neoplasms Neoplasms Genetic Predisposition to Disease Survival Analysis Neoplasm Staging Cisplatin Antineoplastic Combined Chemotherapy Protocols Paclitaxel Survival Rate Xenograft Model Antitumor Assays Pancreatic Neoplasms Cancer Vaccines Reverse Transcriptase Polymerase Chain Reaction BRCA2 Protein Risk Disease Progression Gene Expression Profiling Adenocarcinoma, Clear Cell Mutation BRCA1 Protein Retrospective Studies Risk Factors Prospective Studies Follow-Up Studies Uterine Cervical Neoplasms RNA, Messenger Carcinoma, Endometrioid Peritoneal Neoplasms Neoplasm Recurrence, Local Disease-Free Survival Adenocarcinoma, Mucinous Registries Risk Assessment Endometrial Neoplasms Antineoplastic Agents, Phytogenic United States DNA, Neoplasm Blotting, Western Germ-Line Mutation Age Factors Neoplasm Transplantation Cell Proliferation RNA, Small Interfering Tumor Cells, Cultured Odds Ratio Colorectal Neoplasms Ascites Receptor, erbB-2 Combined Modality Therapy Receptors, Estrogen Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung DNA Methylation Urinary Bladder Neoplasms Apoptosis Cell Survival Questionnaires National Cancer Institute (U.S.)Sensitivity and Specificity Tumor Suppressor Protein p53 Transplantation, Heterologous Carboplatin Cell Transformation, Neoplastic Antigens, Neoplasm Genotype Survivors Multivariate Analysis Kaplan-Meier Estimate Oligonucleotide Array Sequence Analysis Cell Movement Genetic Testing Drug Screening Assays, Antitumor Neoplastic Stem Cells Down-Regulation Smoking Chemotherapy, Adjuvant Genital Neoplasms, Female

No FAQ available that match "hereditary ovarian cancer cancer canadian"